Zymeworks (ZYME) Stock Statistics & Valuation Metrics

Zymeworks has a market cap or net worth of $1.07B. The enterprise value is $708.40M.

Zymeworks has 75,166,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zymeworks’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -33.39%.

The current PE Ratio of Zymeworks is ―. Zymeworks’s PEG ratio is ―.

In the last 12 months, Zymeworks had revenue of 76.30M and earned -122.69M in profits. Earnings per share was -1.62.

In the last 12 months, operating cash flow was -68.51B and capital expenditures 523.62K, giving a free cash flow of -68.51B billion.

Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―

Zymeworks upcoming earnings date is Nov 11, 2025, Before Open (Confirmed).

Zymeworks as a current ratio of 3.40, with Debt / Equity ratio of 5.58%

In the past 12 months, Zymeworks has paid 6.08M in taxes.

Zymeworks EV to EBITDA ratio is -10.08, with an EV/FCF ratio of -9.40.

Zymeworks has $281.38M in cash and marketable securities with $18.68M in debt, giving a net cash position of -$262.70M billion.

Gross margin is 94.83%, with operating margin of -157.03%, and net profit margin of -160.80%.

The average price target for Zymeworks is $21.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy